Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Side effects

TAF only superior to TDF when used with a boosting agent

News
10 April 2018
New & experimental HIV treatments

Powerful new PrEP and treatment drug should be effective as a small weekly pill

News
12 March 2018
New & experimental HIV treatments

Ibalizumab, active against highly resistant HIV, now approved in US

News
8 March 2018
Changing treatment

Biktarvy combo maintains viral suppression after switching therapy

News
7 March 2018
The search for a cure

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

News
5 March 2018
New & experimental HIV treatments

US regulators approve new HIV combo pill containing bictegravir

News
8 February 2018
Injectable & long-acting PrEP

Long-acting injectable ARVs are convenient and private, study participants report

News
17 January 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
New & experimental HIV treatments

Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time

News
28 December 2017
The search for a cure

European Cure Review concentrates on HIV therapeutic vaccines

News
16 November 2017
New & experimental HIV treatments

Symtuza as effective as multi-pill combination in previously untreated people with HIV

News
28 October 2017
People with limited treatment options

Fostemsavir controls viral load in half of people with highly drug-resistant HIV

News
28 October 2017
The search for a cure

ABX464 reduces HIV reservoir but doesn’t delay viral rebound

News
26 October 2017
HIV treatment

Symtuza protease inhibitor regimen maintains viral suppression for a year

News
13 October 2017
Antibody-based treatment

Long-acting monoclonal antibody effective against multidrug-resistant HIV

News
12 October 2017
New & experimental HIV treatments

Maraviroc matches boosted protease inhibitor treatment over 96 weeks

News
11 September 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
The search for a cure

VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

News
2 August 2017
New & experimental HIV treatments

Long-acting NRTI shows promise for HIV treatment and PrEP

News
2 August 2017
New & experimental HIV treatments

First protease inhibitor combination pill maintains viral suppression

News
1 August 2017
New & experimental HIV treatments

Doravirine combination pill looks good for initial HIV treatment

News
27 July 2017
New & experimental HIV treatments

New integrase inhibitor bictegravir works well for first-line HIV treatment

News
25 July 2017
New & experimental HIV treatments

Long-acting cabotegravir + rilpivirine injection shows good results at 96 weeks

News
24 July 2017
New & experimental HIV treatments

Bone density improves in people who switch from tenofovir DF to tenofovir alafenamide

News
27 March 2017